Mark H. Zangmeister Cancer Center — Columbus, Ohio

Mark H. Zangmeister Cancer Center is a clinical research site located in Columbus, Ohio, United States 43219.

Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.

Mark H. Zangmeister Cancer Center has participated in 3 clinical trials with 2 currently active.

Therapeutic areas: Advanced Upper Gastrointestinal Tract Adenocarcinoma, Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer.

Sponsors: Arcus Biosciences, Inc., Mirati Therapeutics Inc., Synta Pharmaceuticals Corp..

Sponsor Feasibility Report

Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mark H. Zangmeister Cancer Center?

Mark H. Zangmeister Cancer Center has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mark H. Zangmeister Cancer Center conducted?

Mark H. Zangmeister Cancer Center has 3 clinical trials on record, with 2 currently active. Their work covers Advanced Upper Gastrointestinal Tract Adenocarcinoma, Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer.

Is Mark H. Zangmeister Cancer Center accredited by Crixeo Health?

Mark H. Zangmeister Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mark H. Zangmeister Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.